Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

March 18, 2025

Study Completion Date

December 31, 2026

Conditions
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue SarcomaMetastatic Bone TumorBone Sarcoma
Interventions
DRUG

Ascorbate

Following 15g test dose, 75g administered 75g dose on days 1 and 2. Further doses of ascorbate will be determined by serum ascorbate levels measured by the end of the week to reach a target serum concentration between 20 -30 mM. Ascorbate doses will continue to be escalated until either the target serum concentration or maximum dose of 125 g is administered.

Trial Locations (1)

52242

John, Iowa City

All Listed Sponsors
collaborator

Mohammed Milhem, MBBS

OTHER

lead

University of Iowa

OTHER